Recent advances in the treatment of malignant melanoma with gene therapy.
作者信息
Hersh E M, Stopeck A T
机构信息
Arizona Cancer Center, Tucson 85724-5024, USA.
出版信息
Mol Med. 1997 Oct;3(10):636-51.
Abstract
摘要
相似文献
1
Recent advances in the treatment of malignant melanoma with gene therapy.基因治疗在恶性黑色素瘤治疗中的最新进展。
Mol Med. 1997 Oct;3(10):636-51.
2
Gene-based therapy of malignant melanoma.恶性黑色素瘤的基因治疗
Semin Oncol. 2002 Oct;29(5):503-12. doi: 10.1053/sonc.2002.35245.
3
[Gene modified tumor vaccines in therapy of malignant melanoma].[基因修饰肿瘤疫苗在恶性黑色素瘤治疗中的应用]
Otolaryngol Pol. 2002;56(2):147-53.
4
Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma.采用颗粒介导转移法用转染GM-CSF基因的自体肿瘤细胞进行免疫接种的I期/Ib期研究，对象为黑色素瘤或肉瘤患者。
Hum Gene Ther. 1997 May 1;8(7):875-91. doi: 10.1089/hum.1997.8.7-875.
5
Advances in gene therapy for malignant melanoma.恶性黑色素瘤基因治疗的进展
Cancer Control. 2002 Jan-Feb;9(1):39-48. doi: 10.1177/107327480200900106.
6
Melanoma vaccines: developments over the past 10 years.黑色素瘤疫苗：过去 10 年的发展。
Expert Rev Vaccines. 2011 Jun;10(6):853-73. doi: 10.1586/erv.11.74.
7
Melanoma vaccines.黑色素瘤疫苗
Dermatol Online J. 2000 Sep;6(1):5.
8
Somatic gene therapy and its implications in melanoma treatment.体细胞基因治疗及其在黑色素瘤治疗中的意义。
Arch Dermatol Res. 1997 Jan;289(2):71-7. doi: 10.1007/s004030050157.
9
Interleukin 7 trials for melanoma treatment.用于黑色素瘤治疗的白细胞介素7试验。
Mol Med Today. 1996 Apr;2(4):144-5. doi: 10.1016/1357-4310(96)88783-1.
10
Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene.一项关于用人白细胞介素-2基因转染的自体癌细胞组成的癌症疫苗对转移性恶性黑色素瘤进行免疫治疗的I期研究。
Hum Gene Ther. 1996 Mar 1;7(4):551-63. doi: 10.1089/hum.1996.7.4-551.
本文引用的文献
1
Interleukin 10 production by human melanoma.人黑色素瘤产生白细胞介素10
Clin Cancer Res. 1996 Aug;2(8):1383-90.
2
3
Alterations in T cell receptor and signal transduction molecules in melanoma patients.黑色素瘤患者T细胞受体及信号转导分子的改变
Clin Cancer Res. 1995 Nov;1(11):1327-35.
4
Decreased antigen presentation by dendritic cells in patients with breast cancer.乳腺癌患者中树突状细胞的抗原呈递减少。
Clin Cancer Res. 1997 Mar;3(3):483-90.
5
Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7.通过直接基因转移同种异体组织相容性抗原HLA - B7对结直肠癌肝转移进行免疫治疗的I期研究
Gene Ther. 1997 May;4(5):419-25. doi: 10.1038/sj.gt.3300396.
6
The development of new cancer therapies based on the molecular identification of cancer regression antigens.基于癌症消退抗原分子鉴定的新型癌症治疗方法的开发。
Cancer J Sci Am. 1995 Jul-Aug;1(2):90-100.
7
8
The TMC Worldwide Gene Therapy Enrollment Report, end 1996.1996年末的TMC全球基因治疗入组报告。
Hum Gene Ther. 1997 Apr 10;8(6):775-800. doi: 10.1089/hum.1997.8.6-775.
9
10
Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A.用来自MART-1/Melan A的肽免疫的黑色素瘤患者的细胞免疫增强。
Cancer J Sci Am. 1997 Jan-Feb;3(1):37-44.
Zotero 插件